Literature DB >> 21443809

Intermittent preventive therapy for malaria: arguments in favour of artesunate and sulphamethoxypyrazine - pyrimethamine combination.

Frans Herwig Jansen1.   

Abstract

Recent publications put a serious warning regarding the inefficacy of sulphadoxine-pyrimethamine (SP) for the intermittent preventive treatment of malaria in young children (IPTi). Recommendations for other therapies are being made. By using a different and better sulphonamide (sulphamethoxypyrazine), it is possible to manufacture fixed dose combination pills with artesunate and pyrimethamine. This combination permits a full therapy over 24 hours (dosing interval being 12 hours). It is recommended that this combination should be tested in future field studies of IPTi.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21443809      PMCID： PMC3078902          DOI： 10.1186/1475-2875-10-70

Source DB:  PubMed          Journal:  Malar J        ISSN： 1475-2875            Impact factor:   2.979


  14 in total

Review 1.  Intermittent preventive treatment against malaria: an update.

Authors:  Roly D Gosling; Matthew E Cairns; R Matthew Chico; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

2.  Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus sulfamethoxypyrazine/pyrimethamine.

Authors:  Stephen Rulisa; Jean Philip Gatarayiha; Tharcisse Kabarisa; Gill Ndayisaba
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

3.  Intermittent preventive treatment of malaria in infancy.

Authors:  Rose McGready
Journal:  Lancet       Date:  2009-09-16       Impact factor: 79.321

4.  A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.

Authors:  Issaka Sagara; Alassane Dicko; Abdoulaye Djimde; Ousmane Guindo; Mamady Kone; Youssouf Tolo; Mahamadou A Thera; Moussa Sogoba; Moussa Fofana; Amed Ouattara; Mady Sissoko; Herwig F Jansen; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

5.  Single-day, three-dose treatment with fixed dose combination artesunate/sulfamethoxypyrazine/pyrimethamine to cure Plasmodium falciparum malaria.

Authors:  Louis Koné Penali; Frans Herwig Jansen
Journal:  Int J Infect Dis       Date:  2008-03-17       Impact factor: 3.623

6.  Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.

Authors:  W E Harrington; T K Mutabingwa; A Muehlenbachs; B Sorensen; M C Bolla; M Fried; P E Duffy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

7.  Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.

Authors:  Badara Cissé; Cheikh Sokhna; Denis Boulanger; Jacqueline Milet; El Hadj Bâ; Keshena Richardson; Rachel Hallett; Colin Sutherland; Kirsten Simondon; François Simondon; Neal Alexander; Oumar Gaye; Geoffrey Targett; Jo Lines; Brian Greenwood; Jean-François Trape
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

8.  A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan.

Authors:  Ishag Adam; Mamoun Magzoub; Maha E Osman; Insaf F Khalil; Michael Alifrangis; Khalid A Elmardi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-08-26       Impact factor: 3.944

9.  Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial.

Authors:  Issaka Sagara; Stephen Rulisa; Wilfred Mbacham; Ishag Adam; Kourane Sissoko; Hamma Maiga; Oumar B Traore; Niawanlou Dara; Yahia T Dicko; Alassane Dicko; Abdoulaye Djimdé; F Herwig Jansen; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-04-14       Impact factor: 2.979

10.  A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.

Authors:  Clara Menéndez; Azucena Bardají; Betuel Sigauque; Cleofé Romagosa; Sergi Sanz; Elisa Serra-Casas; Eusebio Macete; Anna Berenguera; Catarina David; Carlota Dobaño; Denise Naniche; Alfredo Mayor; Jaume Ordi; Inacio Mandomando; John J Aponte; Samuel Mabunda; Pedro L Alonso
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.